Current Report Filing (8-k)
January 19 2021 - 7:10AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
January 15, 2021
Bespoke Extracts, Inc.
|
(Exact name of registrant as specified in its charter)
|
Nevada
|
|
000-52759
|
|
20-4743354
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
323 Sunny Isles Boulevard, Suite 700
Sunny Isles Beach, FL 33160
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including
area code (855) 633-3738
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
(see General Instruction A.2. below):
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
None.
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01 Entry into a Material Definitive Agreement.
On January 15, 2021, Bespoke Extracts,
Inc. (the “Company”) entered into amendments (“Amendment No. 4”) with the holders of the Company’s
original issue discount convertible debentures, with an original issuance date of December 24, 2019, as amended by amendment No.
1 thereto, dated May 28, 2020, amendment No. 2 thereto, dated August 21, 2020, and amendment No. 3 thereto, dated December 10,
2020, in the aggregate outstanding principal amount of $500,000. Pursuant to Amendment No. 4, the conversion price of the debentures
was increased to $0.05 per share (subject to adjustment for stock splits, stock dividends, and similar transactions).
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
Bespoke Extracts, Inc.
|
|
|
|
Date: January 19, 2021
|
By:
|
/s/ Danil Pollack
|
|
|
Danil Pollack
Chief Executive Officer
|
2
Bespoke Extracts (QB) (USOTC:BSPK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bespoke Extracts (QB) (USOTC:BSPK)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Bespoke Extracts Inc (QB) (OTCMarkets): 0 recent articles
More Bespoke Extracts, Inc. News Articles